NCT00004888View on ClinicalTrials.gov

Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

April 30, 2008

Study Completion Date

May 31, 2009

Conditions
Recurrent Breast CancerStage IV Breast Cancer
Interventions
DRUG

pegylated liposomal doxorubicin hydrochloride

Given IV

DRUG

docetaxel

Given IV

BIOLOGICAL

trastuzumab

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

02215

Eastern Cooperative Oncology Group, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00004888 - Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter